MedTrace Logo

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

NCT01862445 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-03-22

No results posted yet for this study

Summary

This is a non interventional study to evaluate the efficacy and safety of Chlorambucil plus Rituximab as firstline therapy in elderly and/or unfit patients affected by B-cell Chronic Lymphocytic Leukemia (B-CLL).

Conditions

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Luca Laurenti, Dr. · Istituto di Ematologia, Università Cattolica del Sacro Cuore di Roma

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01862445 on ClinicalTrials.gov